NEW YORK, Dec. 4 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company
(NYSE: BMY) today announced that Alan J. Lacy has been elected to its Board
of Directors, effective January 2, 2008. Lacy will serve as a member of the
Audit Committee.
Lacy, 54, is currently a senior advisor to Oak Hill Capital Partners,
L.P., a private equity investment firm. From 1994 to 2006, he was employed
by Sears, Roebuck and Co. and following the acquisition of the company,
Sears Holdings Corporation. He held executive level positions of increasing
responsibility in finance and operations, including his service as chief
executive officer from 2000 to 2005. He also served as vice chairman from
2005 to 2006.
"We are very pleased to have a person of Alan's broad business and
financial experience join our Board," said James D. Robinson III, chairman,
Bristol-Myers Squibb. "His addition adds to an already outstanding group of
directors."
"Alan is a man of high integrity and business acumen," added James M.
Cornelius, chief executive officer, Bristol-Myers Squibb. "We look forward
to his contributions as a director of our company as we continue to evolve
into a next generation biopharma enterprise."
Bristol-Myers Squibb is a global biopharmaceutical and related
healthcare products company whose mission is to extend and enhance human
life.
SOURCE Bristol-Myers Squibb Company
 back to top
Related links:
http://www.bms.com
CONTACT:
Media, Jeff Macdonald, Communications,
+1-212-546-4824, jeffrey.macdonald@bms.com, or Investors, John
Elicker, Investor Relations, +1-212-546-3775,
john.elicker@bms.com, both of Bristol-Myers Squibb Company
|
